April 7, 2022 — RaySearch Laboratories AB announces that Mevion China has placed an order for RayStation which Mevion China has sold together with Mevion’s HYPERSCAN proton therapy system to Tongji Hospital in Wuhan in China. RaySearch and Mevion have been collaborating since 2014.
April 6, 2022 — Research in the March 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network examined data from the Ontario Cancer Registry from September 25, 2016 through September 26, 2020, to determine the impact of the COVID-19 pandemic on the number of new cancer cases detected. They found 358,487 adult patients had a new cancer diagnosed during that time period.
April 6, 2022 — Guerbet, a global leader in medical imaging offering a comprehensive range of pharmaceutical products, medical devices, and digital and artificial intelligence (AI) solutions for diagnostic and interventional imaging, has recently submitted a New Drug Application (NDA) to the U.S.
April 5, 2022 — The American College of Radiology (ACR) has selected 22 teams as the first cohort of the ACR Learning Network, a new initiative to improve diagnostic imaging through a learning health system approach. Funded by a grant from the Gordon and Betty Moore Foundation, four improvement collaboratives will address important areas of performance in cancer diagnosis.
